AI in Life Sciences

Implement AI faster without losing compliance

AI is reshaping digital operations across life sciences. Yet deploying AI within a GxP-regulated environment brings distinct risks — particularly when data is distributed across disparate systems and workflows.

Without solid foundations, organizations encounter hurdles such as fragmented data, gaps in audit trails, and limited traceability. Model transparency and explainability are also drawing increased regulatory attention during inspections. Moreover, because AI models continuously evolve, a structured lifecycle management strategy — aligned with CSA principles — is indispensable.

In this interactive session, QbD Group and delaware present how their combined strengths deliver a pragmatic, integrated, and validated approach to AI adoption in regulated life sciences settings, helping you transition from proof-of-concept to compliant deployment with confidence.

QbD Group partners with life sciences organizations across the globe to uphold the highest quality and safety standards — from concept to patient — leveraging expertise in quality assurance, regulatory compliance, clinical services, and digital solutions.

delaware is a global consultancy and SAP Platinum Partner that helps organizations navigate business and digital transformation through comprehensive IT and enterprise technology solutions.

Together, we enable life sciences companies to close the gap between technology and compliance — making sure every digital initiative is validated, inspection-ready, and future-proof from the start.

Our expertise in software implementation, validation, and IT partnerships bridges the gap between regulatory requirements, business processes, and technology. Whether you want to modernize workflows, enhance data utilization, or future-proof your systems, we guide you every step of the way.